Cardiac syndrome X in women: The role of oestrogen deficiency

Heart

Volumn 92, Issue SUPPL. 3, 2006, Pages

  Kaski, J C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL DYSFUNCTION; ESTROGEN DEFICIENCY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HORMONE SUBSTITUTION; MICROANGIOPATHY; NOCICEPTION; PRIORITY JOURNAL; REVIEW; SYNDROME X; THORAX PAIN;

ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MICROCIRCULATION; MICROVASCULAR ANGINA; MYOCARDIAL ISCHEMIA; NOCICEPTORS;

EID: 33646250191     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.070318     Document Type: Review

References (53)

1. Kaski JC, Rosano GM, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
2. Galassi AR, Kaski JC, Crea F, et al. Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 1991;122:458-63.
3. Gavrielides S, Kaski JC, Galassi AR, et al. Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X. Am Heart J 1991;122:1593-8.
4. Cannon RO III, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992;85:883-92.
5. Mendelsohn ME, Karas RH. The protective effects of oestrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
6. Masci PG, Laclaustra M, Lara JG, et al. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005;95:1478-80.
7. Zeiher AM, Krause T, Schachinger V, et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-52.
8. Rosano GM, Peters NS, Kaski JC, et al. Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans. Am J Cardiol 1995;75:400-2.
9. Fragasso G, Rossetti E, Dosio F, et al. High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1990;17:1482-7.
10. Kaski JC. Cardiac imaging in syndrome X: the problem of "reverse redistribution". Eur Heart J 1996;17:1459-61.
11. Poole-Wilson PA. Potassium and the heart. Clin Endocrinol Metab 1984;13:249-68.
12. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.
13. Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000;342:829-35.
14. Buffon A, Rigattieri S, Santini SA, et al. Myocardial ischaemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol 2000;279:H2627-33.
15. Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
16. Kaski JC, Elliott PM, Dickinson K, et al. Plasma endothelin-1 concentration in patients with angina and normal coronary arteriograms. Br Heart J 1995;73:P73.
17. Kolasinska-Kloch W, Lesniak W, Kiec-Wilk B, et al. Biochemical parameters of endothelial dysfunction in cardiological syndrome X. Scand J Clin Lab Invest 2002;62:7-13.
18. Cox ID, Botker HE, Bagger JP, et al. Elevated endothelin concentrations are associated with reduced coronary vascomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol 1999;34:455-60.
19. Chauhan A, Foote J, Petch MC, et al. Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 1994;23:364-8.
20. Newby DE, Flint LL, Fox KA, et al. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X. J Am Coll Cardiol 1998;31:1585-90.
21. Swan JW, Walton C, Godsland IF, et al. Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 1994;71:41-4.
22. Cosin-Sales J, Pizzi C, Brown S, et al. C-Reactive protein, clinical presentation and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003;41:1468-74.
23. Kaski JC. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 2002;53:620-6.
24. Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000;46:28-49.
25. Volterrani M, Rosano G, Coats A, et al. Oestrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995;99:119-22.
26. Roque M, Heras M, Roig E, et al. Short-term effects of transdermal oestrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998;31:139-43.
27. Collins P, Rosano GM, Sarrel PM, et al. 17 beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30.
28. Chester AH, Jiang C, Borland JA, et al. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis 1995;6:417-22.
29. Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of oestrogen in postmenopausal women. Circulation 1994;90:786-91.
30. Mendelsohn ME, Karas RH. The protective effects of oestrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
31. Kennedy SE, Zubieta JK. Neuroreceptor imaging of stress and mood disorders. CNS Spectr 2004;9:292-301.
32. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001;293:311-5.
33. Zubieta JK, Smith YR, Bueller JA, et al. mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 2002;22:5100-7.
34. Ribeiro SC, Kennedy SE, Smith YR, et al. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1264-80.
35. Albertsson PA, Emanuelsson H, Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 1996;54:13-20.
36. Rosano GM, Peters NS, Lefroy D, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500-5.
37. Rosano GM, Lindsay DC, Poole-Wilson PA. Syndrome X: an hypothesis for cardiac pain without ischaemia. Cardiologia 1991;36:885-95.
38. Paoletti R, Wenger NK. Review of the international position on women's health and menopause: a comprehensive approach. Circulation 2003;107:1336-9.
39. Chauhan A, Mullins PA, Thuraisingham SI, et al. Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol 1994;24:329-35.
40. Turiel M, Galassi AR, Glazier JJ. Pain threshold and tolerance in women with syndrome x and women with stable angina pectoris. Am J Cardiol 1987;60:503-7.
41. Botker HE, Sonne HS, Frobert O, et al. Enhanced exercise-induced hyperkalemia in patients with syndrome X. J Am Coll Cardiol 1999;33:1056-61.
42. Botker HE, Moller N, Schmitz O, et al. Myocardial insulin resistance in patients with syndrome X. J Clin Invest 1997;100:1919-27.
43. Rosen SD, Paulesu E, Wise RJ, et al. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002;87:513-19.
44. Rosen SD, Paulesu E, Frith CD, et al. Central nervous pathways mediating angina pectoris. Lancet 1994;344:147-50.
45. Rosen SD, Paulesu E, Nihoyannopoulos P. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124:939-49.
46. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-9.
47. Magni G. The use of antidepressants in the treatment of chronic pain. A review of the current evidence. Drugs 1991;42:730-48.
48. Cannon RO III, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-17.
49. Cox ID, Hann CM, Kaski JC. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J 1998;19:250-4.
50. Mannheimer C, Carlsson CA, Emanuelsson H, et al. The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation 1985;71:308-16.
51. Sanderson JE, Woo KS, Chung HK, et al. The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X. Coron Artery Dis 1996;7:547-52.
52. Eliasson T, Albertsson P, Hardhammar P, et al. Spinal cord stimulation in angina pectoris with normal coronary arteriograms. Coron Artery Dis 1993;4:819-27.
53. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004;109:568-72.